Literature DB >> 11762977

Methadone: the question or the answer for US opioid therapy and pharmaco-economics?

E D Dickerson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11762977     DOI： 10.1007/s005200100266

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  11 in total

1.  Opioids in cancer pain--which one is best?

Authors:  C H Wilder-Smith
Journal:  Support Care Cancer       Date:  2001-03       Impact factor: 3.603

Review 2.  Clinical applications of methadone.

Authors:  W L Wheeler; E D Dickerson
Journal:  Am J Hosp Palliat Care       Date:  2000 May-Jun       Impact factor: 2.500

Review 3.  Palliative care and hospice opioid dosing guidelines with breakthrough pain (BP) doses.

Authors:  M Pappagallo; E D Dickerson; S Hulka
Journal:  Am J Hosp Palliat Care       Date:  2000 Nov-Dec       Impact factor: 2.500

4.  A German model for methadone conversion.

Authors:  F Nauck; C Ostgathe; E D Dickerson
Journal:  Am J Hosp Palliat Care       Date:  2001 May-Jun       Impact factor: 2.500

5.  Criteria for opioid selection.

Authors:  C Benedetti; E D Dickerson
Journal:  J Pain Symptom Manage       Date:  2000-06       Impact factor: 3.612

Review 6.  Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration.

Authors:  M P Davis; D Walsh
Journal:  Support Care Cancer       Date:  2001-03       Impact factor: 3.603

Review 7.  New approaches to pain control in patients with cancer.

Authors:  S Ahmedzai
Journal:  Eur J Cancer       Date:  1997-07       Impact factor: 9.162

8.  Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.

Authors:  E Bruera; J Pereira; S Watanabe; M Belzile; N Kuehn; J Hanson
Journal:  Cancer       Date:  1996-08-15       Impact factor: 6.860

9.  Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?

Authors:  C Ripamonti; L Groff; C Brunelli; D Polastri; A Stavrakis; F De Conno
Journal:  J Clin Oncol       Date:  1998-10       Impact factor: 44.544

10.  Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.

Authors:  S Mercadante; A Casuccio; A Agnello; R Serretta; L Calderone; L Barresi
Journal:  J Clin Oncol       Date:  1998-11       Impact factor: 44.544
View more
  3 in total

Review 1.  Methadone for treatment of cancer pain.

Authors:  John Bryson; Anoo Tamber; Dori Seccareccia; Camilla Zimmermann
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

2.  Methadone initiation and rotation in the outpatient setting for patients with cancer pain.

Authors:  Henrique A Parsons; Maxine de la Cruz; Badi El Osta; Zhijun Li; Bianca Calderon; J Lynn Palmer; Eduardo Bruera
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

3.  The source of methadone in overdose deaths in Western Virginia in 2004.

Authors:  Melissa B Weimer; P Todd Korthuis; George S Behonick; Martha J Wunsch
Journal:  J Addict Med       Date:  2011-09       Impact factor: 3.702
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.